Home > Healthcare > Medical Devices > Diagnostic Devices > reflux testing devices market
Get a free sample of Reflux Testing Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Reflux Testing Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Reflux Testing Devices Market was valued at USD 3.2 billion in 2022 and is estimated to account for USD 5 billion by 2032 driven by the increasing prevalence of gastroesophageal reflux disease (GERD). Lifestyle changes, dietary habits, and an aging population base have contributed to the rising number of individuals experiencing GERD-related symptoms, such as heartburn and regurgitation. As awareness of the potential complications of untreated GERD grows among patients and healthcare providers, there is a heightened demand for accurate diagnostic tools and monitoring devices.
The growing elderly population base suffering from GERD is a major factor stimulating the demand for reflux testing devices. For instance, nearly 11 million people, or 19% of the population, are over the age of 65 today. In another ten years, this is going to grow to roughly 13 million people, or 22% of the population. Such rise in geriatric population base will increase the demand for reflux testing and monitoring. Older people are more likely to have GERD, which, if unaddressed, can cause serious consequences. In addition, due to age-related changes in the digestive tract, number of individuals are at risk for developing GERD with time that has been observed in the global elderly population. As a result, there is an increasing demand for precise diagnostic instruments and monitoring systems to evaluate the severity of GERD and direct individualized treatment regimens.
Medtronic, Biomedix, Johnson & Johnson Services, Inc, Diversatek, Inc., Laborie, Diversatek Healthcare, Creo Medical Group PLC, JINSHAN Science & Technology (Group) Co., Ltd., and Thermo Fisher Scientific are some of the major reflux testing device companies worldwide.
U.S. industry recorded USD 1 billion in revenue in 2022 and will experience appreciable growth from 2023-2032 owing to the presence of highly developed healthcare infrastructure in the region.
The reflux capsule product type segment will register 5.2% CAGR from 2023-2032 on account of their patient-friendly approach along with remarkable technological advancements.
Reflux testing devices market size was USD 3.2 billion in 2022 and will reach USD 5 billion by 2032 due to the increasing prevalence of gastroesophageal reflux disease (GERD) worldwide.